Floatz logo

Aldurazyme

Hurler-Scheie Syndrome

Genzyme, a Sanofi CompanyPhase 4 / ApprovedDormant
A
84/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
77/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Hurler-Scheie Syndrome cohort.

Asset / SponsorPhaseRating
IDURONIDASE, .ALPHA.-L-(8-HISTIDINE) (HUMAN)
Genzyme, a Sanofi Company
Phase 4BB
Rhidu
Genzyme, a Sanofi Company
Phase 3BB
Rgx-111
REGENXBIO Inc.
Phase 1/2CCC

Same molecule, other indications

Aldurazyme is also rated in:

mucopolysaccharidosis type 1Dormant
A
Indicative ·
84 / 100
View asset →
Hurler syndromeDormant
A
Indicative ·
84 / 100
View asset →
Scheie syndromeDormant
A
Indicative ·
84 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →